ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	12/72	120/7206	1.72723524485e-09
ko04064	NF-kappa B signaling pathway	10/72	96/7206	2.96990106167e-08
ko04621	NOD-like receptor signaling pathway	12/72	157/7206	3.73433425442e-08
ko04060	Cytokine-cytokine receptor interaction	13/72	191/7206	3.81737321935e-08
ko04380	Osteoclast differentiation	9/72	134/7206	6.41454835096e-06
ko05321	Inflammatory bowel disease (IBD)	6/72	56/7206	1.76294204475e-05
ko04658	Th1 and Th2 cell differentiation	7/72	96/7206	4.34382714868e-05
ko05161	Hepatitis B	9/72	173/7206	4.99226766789e-05
ko05160	Hepatitis C	8/72	153/7206	0.000130204219055
ko05212	Pancreatic cancer	6/72	83/7206	0.000165749807306
ko04662	B cell receptor signaling pathway	6/72	88/7206	0.000228817490151
ko04210	Apoptosis	8/72	180/7206	0.000396610636821
ko04620	Toll-like receptor signaling pathway	6/72	100/7206	0.000458080091288
ko05152	Tuberculosis	8/72	187/7206	0.000512101390685
ko05167	Kaposi's sarcoma-associated herpesvirus infection	8/72	191/7206	0.000589499417554
ko05166	HTLV-I infection	10/72	292/7206	0.000590420175781
ko04660	T cell receptor signaling pathway	6/72	124/7206	0.00142177729701
ko01522	Endocrine resistance	6/72	124/7206	0.00142177729701
ko04657	IL-17 signaling pathway	5/72	87/7206	0.00169400482895
ko05142	Chagas disease (American trypanosomiasis)	6/72	130/7206	0.00181160681826
ko05323	Rheumatoid arthritis	5/72	89/7206	0.00187386611302
ko04217	Necroptosis	7/72	178/7206	0.00189896962994
ko04630	Jak-STAT signaling pathway	6/72	132/7206	0.00195809060299
ko04932	Non-alcoholic fatty liver disease (NAFLD)	7/72	182/7206	0.00215532422546
ko04933	AGE-RAGE signaling pathway in diabetic complications	6/72	135/7206	0.00219446239393
ko04931	Insulin resistance	6/72	137/7206	0.0023636339676
ko05146	Amoebiasis	5/72	99/7206	0.00298971723125
ko04622	RIG-I-like receptor signaling pathway	4/72	62/7206	0.00330233835199
ko04659	Th17 cell differentiation	5/72	106/7206	0.00401420629617
ko04010	MAPK signaling pathway	9/72	321/7206	0.00441927992842
ko05215	Prostate cancer	5/72	111/7206	0.00488548231195
ko04672	Intestinal immune network for IgA production	3/72	37/7206	0.00582656955988
ko04068	FoxO signaling pathway	6/72	167/7206	0.00626004229661
ko05418	Fluid shear stress and atherosclerosis	6/72	173/7206	0.00740676074694
ko04218	Cellular senescence	6/72	177/7206	0.00825140946805
ko05131	Shigellosis	4/72	82/7206	0.00891784262807
ko05200	Pathways in cancer	11/72	492/7206	0.00908752975634
ko05168	Herpes simplex infection	6/72	182/7206	0.00940247164177
ko05220	Chronic myeloid leukemia	4/72	85/7206	0.0100956640384
ko05210	Colorectal cancer	4/72	86/7206	0.0105096477168
ko04920	Adipocytokine signaling pathway	4/72	89/7206	0.01181721027
ko05219	Bladder cancer	3/72	48/7206	0.0119955201015
ko05120	Epithelial cell signaling in Helicobacter pylori infection	4/72	92/7206	0.0132252928376
ko05169	Epstein-Barr virus infection	6/72	206/7206	0.0165672229378
ko00254	Aflatoxin biosynthesis	1/72	2/7206	0.0198848865828
ko01521	EGFR tyrosine kinase inhibitor resistance	4/72	106/7206	0.021195145244
ko04071	Sphingolipid signaling pathway	5/72	162/7206	0.022551932819
ko05213	Endometrial cancer	3/72	62/7206	0.0237605156995
ko05164	Influenza A	5/72	167/7206	0.025321903336
ko05223	Non-small cell lung cancer	3/72	66/7206	0.0279512026763
ko05224	Breast cancer	5/72	174/7206	0.029555287817
ko05206	MicroRNAs in cancer	5/72	177/7206	0.0314992225304
ko01523	Antifolate resistance	2/72	30/7206	0.0357682302397
ko05145	Toxoplasmosis	4/72	126/7206	0.0368467790602
ko05134	Legionellosis	3/72	74/7206	0.0374348915588
ko04320	Dorso-ventral axis formation	2/72	31/7206	0.0379923884821
ko01524	Platinum drug resistance	3/72	76/7206	0.0400328534213
ko04072	Phospholipase D signaling pathway	5/72	197/7206	0.0465100447411
ko05230	Central carbon metabolism in cancer	3/72	81/7206	0.0469178231852